Clinical Trial Update: Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection

View source ↗

Summary

This clinical trial update notes that a cellular immunotherapy study for relapsed or refractory non-Hodgkin lymphoma is actively recruiting and collects data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Lymphoma, Non-Hodgkin | Status: RECRUITING